Finland· FI-REL-REL43347
Amlodipin/Atorvastatin Ratiopharm
A atorvastatin and amlodipine product containing atorvastatin calcium + amlodipine besylate, registered in Finland by ratiopharm GmbH. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Atorvastatin and amlodipine is registered in 7 of 19 countries.
Countries holding a registration under ATC C10BX03 (atorvastatin and amlodipine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 6 of them publish a price we can compare per daily dose
Atorvastatin and amlodipine · ATC C10BX03
7 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Polandprice
- Switzerlandprice
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Atorvastatin calcium + Amlodipine besylate
- Manufacturer
- ratiopharm GmbH
- Country
- Finland (FI)
- ATC code
- C10BX03
- ATC class
- Atorvastatin and amlodipine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for atorvastatin and amlodipine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Atorvastatin and amlodipine · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Atorvastatin and amlodipine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAmlodipine and atorvastatinMylan Pharmaceuticals Inc.
- CzechiaCADUETVIATRIS HEALTHCARE LIMITED, Dublin
- CanadaAPO-AMLODIPINE-ATORVASTATINAPOTEX INC
- SpainAMLODIPINO/ATORVASTATINA KRKA 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGKrka D.D. Novo Mesto
- FranceCADUET 10 mg/10 mg, comprimé pelliculéBB FARMA (ITALIE)
- PolandAmlatorGedeon Richter Plc.
- SwitzerlandCaduet
- GermanyAmloatorApontis Pharma Deutschland Gmbh & Co. Kg
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Atorvalan Comp., Caduet
- Bulgaria · Амлатор, Атордапин
- Czechia · Amlator, Caduet
- Germany · Amloator
- Spain · Amlodipino/Atorvastatina Krka, Amlodipino/Atorvastatina Normon
- France · Amlodipine/Atorvastatine Viatris, Caduet
- Croatia · Atordapin, Caduet
- Hungary · Amlator, Caduet
- Lithuania · Atordapin
- Latvia · Atordapin, Caduet
- Poland · Amlator
- Portugal · Caduet, Trinalion
- Romania · Caduet, Lirtonen
- Slovenia · Amaloris, Lirtonen
- Slovakia · Amlator, Dicartil
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3df9aa95-349e-4088-8716-5264f7918ccd GET /v1/drugs/3df9aa95-349e-4088-8716-5264f7918ccd?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": null,
"strength": "5 mg / 10 mg",
"atc_label": "atorvastatiini ja amlodipiini",
"ma_number": "31362",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL43347",
"authorised_at": "2014-09-10"
}See everything about atorvastatin and amlodipine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.